Conditions

Dr. Stanley Schwartz talks about why he doesn’t think that sulfonylureas should be used any longer, emphasizing that although they were useful when there were no alternatives, there are far safer and better drugs available today. More videos in this series with Dr. Schwartz Stanley Schwartz, MD, FACP, FACE: Introduction, …

Dr. Stanley Schwartz talks about the best way to determine beta cell function and says that there are actually several indicators that might need to be used. He suggests that there may be several steps that need to be taken including genotyping patients, looking at both classic markers and newer …

Dr. Stanley Schwartz talks about addressing the epidemic of not only diabetes but the growing numbers of prediabetes patients. He reviews the current policy situation and then talks about how he proceeds in his practice with prediabetes patients.  He points out that several studies have shown that adding certain medications …

  Dr. Stanley Schwartz addresses the question of, “Where do we go from here?” regarding the beta-cell centric approach. He notes that there are two ways to approach the question — grassroots and a top-down approach — and says that both avenues should be pursued. He hopes that his his …

Low HDL increases the risk of heart disease but does it also increase the risk of cancer?…

Eating a lot of higher fat dairy products seemed to lower the risk of type 2 diabetes development by up to 23%…. 

Overweight diabetic patients who lose weight by dieting and increasing their physical activity can reduce their health care costs by an average of around $600 per year…. 

This study showed that fenofibrate was very effective in lowering total, LDL, non-HDL cholesterol significantly in female diabetic patients compared to male patients…. 

In patients with type 2 diabetes, LX4211 produced greater dose-ranging effects on HbA1c than on glucosuria…. 

Vagal nerve blockade might not be an effective therapy for obesity treatment….